HOME>Investor Relations

Investor Relations

Share Price Information

IR Calendar

2019
May 10
Announcement of FY2018 Financial Results
February 4
Announcement of FY2018 3rd Quater Financial Results

What's New

  • RSS
  • About RSS

News Release List

2019
April 15 Release For the ALS patients in the world, we hope to deliver Japan-originated ALS treatment―NMPA accepts our filing for Radicut to treat ALS in ChinaPDF
April 11 Release Notice Regarding Reorganization of Research, Production, and Technology BasesPDF
March 28 Release The Global Health Innovative Technology Fund provides grant for joint research into anti-malarial drugs conducted by Mitsubishi Tanabe Pharma and a malaria research institutionPDF
March 20 Release Aiming to expand our sales and to strengthen our business foundations in the growing ASEAN market Establishment of sales subsidiary in Malaysia and Vietnam Representative OfficePDF
March 12 Release Topline Results of Japanese Phase 3 Clinical Studies of the HIF-PH Inhibitor MT-6548 in Anemia due to CKDPDF
February 28 Release Tianjin Tanabe and Servier Tianjin join hands to promote TENELIA in ChinaPDF
February 20 Release Mitsubishi Tanabe Pharma Received Notice of Request for ArbitrationPDF
February 14 Release FDA accepted an Investigational New Drug Application for MT-8633, an ADC Targeting cMet Positive Solid TumorsPDF
February 12 Release First Initiative in Digital Medicine Notice Regarding the Start of a Demonstration Project for TOMOCO, a Diabetes Care AppPDF
February 7 Topics IR Meeting for FY2018 3rd Quarter Business Results[Transcript]
February 6 Release Swissmedic approves RADICAVA, Japan-originated ALS treatmentPDF
February 4 Topics IR Meeting for FY2018 3rd Quarter Business Results[Material][Audio]
February 4 Release Announcement of FY2018 3rd Quarter Financial Results
⇒R&D Pipeline "State of New Product Development"
February 4 Release Notice Regarding Conclusion of Stock Transfer Agreement for Tanabe Seiyaku Yoshiki Factory Co., Ltd.PDF
  • FTSE4Good
  • FTSE Blossom Japan
  • MSCI日本株女性活躍指数
  • MSCIジャパンESGセレクトリーダーズ指数
  • JPX-NIKKEI 400

Investor Relations

Share Price Information

ReadSpeaker docReader makes documents accessible to all users including users with vision problems letting users view and listen to texts.
User guide